EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Abnormal lipid profiles are associated with markers of impaired fibrinolysis in patients with cirrhosis

Fynn L Elvers, Jelle Adelmeijer, Marilena Stamouli, William Bernal, Vishal C Patel, Ton Lisman

Research and Practice in Thrombosis and Haemostasis · 2026-10 · 10 (7) · 106975

DOI: 10.1016/j.rpth.2026.106975 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Research and Practice in Thrombosis and Haemostasis, 2026-10. Verfasst von Fynn L Elvers und 5 weiteren Autor:innen. Beteiligte Einrichtung: Surgical Research Laboratory and Section of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, University Medical Center Groning…. Hauptthemen laut MEDLINE: Liver Cirrhosis, Fibrinolysis, Lipids, Dyslipidemias. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King's College Hospital Charity, UMCG, Rijksuniversiteit Groningen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with liver cirrhosis exhibit abnormalities in lipid metabolism and in circulating proteins of clot breakdown. Recent studies have shown relationships between dyslipidemia and fibrinolytic abnormalities in noncirrhotic populations.

Objectives

We investigated associations between lipid profiles and fibrinolytic markers in patients with cirrhosis.

Methods

This observational study analyzed samples from 147 patients with stable cirrhosis, decompensated cirrhosis, acute-on-chronic liver failure, and sepsis without pre-existing chronic liver disease, and from 38 healthy controls. We studied fibrinolysis by clot lysis time (CLT), plasminogen, plasminogen activator inhibitor-1 (PAI-1), and tissue-type plasminogen activator (tPA), and lipid profiles by apolipoproteins A1 and B, common lipoproteins, triglycerides, and total cholesterol.

Results

CLT was slightly enhanced in stable and decompensated cirrhosis, but prolonged in acute-on-chronic liver failure and sepsis. Plasminogen levels decreased, whereas PAI-1 and tPA increased with cirrhosis severity. All lipid parameters decreased with cirrhosis severity, besides triglyceride levels, which were preserved. In an analysis of all patients with cirrhosis combined, apolipoprotein A1 correlated inversely with CLT, levels of PAI-1 and tPA, and positively with plasminogen. Apolipoprotein B, low-density lipoprotein, and lipoprotein(a) correlated positively with plasminogen. Triglycerides correlated positively with CLT.

Conclusion

Cirrhosis is characterized by decreased (apo)lipoprotein levels, preserved triglyceride levels, and a shift from enhanced to impaired fibrinolysis with increasing disease severity. Lower apolipoprotein A1 levels and higher triglyceride levels are associated with impaired fibrinolysis, which may reflect biological interactions between lipid metabolism and fibrinolysis or parallel alterations secondary to hepatic dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisFibrinolysisLipidsDyslipidemiasHumansMaleFemaleMiddle AgedBiomarkersPlasminogen Activator Inhibitor 1SepsisPlasminogenTissue Plasminogen ActivatorAgedAdultFibrin Clot Lysis TimeAcute-On-Chronic Liver FailureCase-Control StudiesTriglyceridesApolipoprotein A-ISeverity of Illness Index

Stichwörter der Autor:innen

apolipoprotein A-Idyslipidemiasfibrin clot lysis timefibrinolysisliver cirrhosissepsisthrombosistriglycerides

Substanzen

BiomarkersPlasminogen Activator Inhibitor 1LipidsPlasminogenTissue Plasminogen ActivatorTriglyceridesApolipoprotein A-ISERPINE1 protein, human

Autor:innen und Institutionen

  • Surgical Research Laboratory and Section of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Roger Williams Institute of Liver Studies, School of Immunology & Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, Foundation for Liver Research and King's College Hospital, London, UK.
  • Liver Intensive Therapy Unit, Institute of Liver Studies, King's College Hospital, Denmark Hill, London, UK.

Förderung

  • King's College Hospital Charity
  • UMCG
  • Rijksuniversiteit Groningen
  • Foundation for Liver Research

Zitieren

APA

Elvers, F. L., Adelmeijer, J., Stamouli, M., Bernal, W., Patel, V. C., & Lisman, T. (2026). Abnormal lipid profiles are associated with markers of impaired fibrinolysis in patients with cirrhosis. Research and Practice in Thrombosis and Haemostasis, 10(7), 106975. https://doi.org/10.1016/j.rpth.2026.106975

Vancouver

Elvers FL, Adelmeijer J, Stamouli M, Bernal W, Patel VC, Lisman T. Abnormal lipid profiles are associated with markers of impaired fibrinolysis in patients with cirrhosis. Research and Practice in Thrombosis and Haemostasis. 2026;10(7):106975. doi:10.1016/j.rpth.2026.106975

BibTeX
@article{Elvers2026,
  author = {Elvers, Fynn L and Adelmeijer, Jelle and Stamouli, Marilena and Bernal, William and Patel, Vishal C and Lisman, Ton},
  title = {Abnormal lipid profiles are associated with markers of impaired fibrinolysis in patients with cirrhosis},
  journal = {Research and Practice in Thrombosis and Haemostasis},
  year = {2026},
  volume = {10},
  number = {7},
  pages = {106975},
  doi = {10.1016/j.rpth.2026.106975}
}
Kostenlos starten →